Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Downgrades and Decreased Price Targets for Levi Strauss Co

Elaine Mendonca by Elaine Mendonca
January 16, 2024
in Breaking News
0
Food Retailers Market Capitalization
0
SHARES
17
VIEWS
Share on FacebookShare on Twitter

On January 16, 2024, Levi Strauss & Co. (LEVI) received a downgrade from Wells Fargo analyst Ike Boruchow. The analyst revised the stock’s rating from Overweight to Equal-Weight and set a price target of $18. This adjustment indicates that Wells Fargo no longer anticipates the stock to outperform the market average and has established a target price of $18.

This downgrade aligns with other recent downgrades of Levi Strauss, including BofA Securities’ downgrade from Buy to Neutral. BofA Securities also decreased their price target for the stock from $19 to $17.

LEVI Stock Performance on January 16, 2024: Stable Trading Above Moving Average, Pre-Market Decline

LEVI Stock Performance on January 16, 2024:

– LEVI finds itself trading in the middle of its 52-week range, indicating stability.
– LEVI is currently trading above its 200-day simple moving average, indicating an upward trend.
– The price of LEVI shares decreased by $0.35 or 2.15% since the market last closed.
– LEVI’s closing price on the previous market day was $15.90.
– LEVI experienced a further decline of $0.33 during pre-market trading.
– It is important to consider market trends, investor sentiment, and company-specific news when analyzing stock performance.
– Investors should closely monitor LEVI’s stock performance and conduct thorough research before making investment decisions.

LEVI Stock Soars on Strong Revenue Growth: Impressive Financial Performance in 2024

LEVI Stock Performance Soars on Strong Revenue Growth

On January 16, 2024, Levi Strauss & Co. (LEVI) experienced a significant surge in its stock performance. The company reported total revenue of $6.17 billion over the past year, representing a 6.96% increase compared to the previous year. The total revenue for the most recent quarter reached $1.51 billion, indicating a remarkable 13.14% increase compared to the previous quarter.

This strong revenue growth showcases the company’s ability to generate consistent and substantial sales. The positive momentum in revenue growth bodes well for the future prospects of LEVI stock.

In terms of net income, Levi Strauss & Co. reported a net income of $569.10 million over the past year. The net income for Q3 reached $9.60 million, marking a remarkable 700.0% increase compared to the previous quarter.

This surge in net income indicates that Levi Strauss & Co. has successfully managed its expenses and improved its profitability. Such positive financial performance is likely to instill confidence in investors, further fueling the upward trajectory of LEVI stock.

Earnings per share (EPS) also witnessed substantial growth for Levi Strauss & Co. Over the past year, the company reported an EPS of $1.41, reflecting a 4.32% increase compared to the previous year. The most recent quarter’s EPS reached $0.02, indicating an impressive 697.5% increase compared to the previous quarter.

The significant growth in EPS is a clear indicator of the company’s ability to generate higher profits for its shareholders. As earnings per share continue to rise, investors can expect a positive impact on the overall valuation of LEVI stock.

Overall, the strong financial performance of Levi Strauss & Co. on January 16, 2024, has propelled the company’s stock to new heights. The impressive revenue growth, coupled with the significant increase in net income and earnings per share, has attracted investors seeking to capitalize on the company’s success.

Investors are likely to view Levi Strauss & Co. as a promising investment opportunity, given its ability to consistently deliver strong financial results. As the company continues to execute its growth strategies and capitalize on market opportunities, the future looks bright for LEVI stock.

Tags: LEVI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Entertainment Markets and money

Bowlero Corporation Expands National Presence with Acquisitions and New Openings

Biotechnology Trading online

Allakos Shifts Focus to AK006 and Other Preclinical Programs A Strategic Move in Biotechnology Development

Banking Markets and money

Guaranty Bancshares Quarterly Earnings Report Mixed Results with Decreased Earnings and Sales

Recommended

UBS Stock

UBS Faces Critical Test as Quarterly Results Loom

2 months ago
Franklin FTSE India ETF Stock

India’s Growth Narrative Fails to Stem ETF Outflows

7 months ago
Technology Quantum computing Stock Exchange

Innovid Announces Fourth Quarter 2023 Financial Results and Provides Guidance for Full Year

2 years ago
Opendoor Stock

Opendoor Shares Face Sharp Correction Following Record Rally

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Dell’s Quantum Security Push Amidst AI-Driven Growth

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Trending

Zscaler Stock
Analysis

Zscaler’s Upward Revision: Security Demand in the AI Era Fuels Optimism

by Rodolfo Hanigan
March 25, 2026
0

At the recent RSA Conference, Zscaler’s leadership outlined a compelling vision, framing the company as a critical...

Coherent Stock

Coherent Stock Accelerates Toward New Highs on Key Breakthroughs

March 25, 2026
Corning Stock

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Dell Stock

Dell’s Quantum Security Push Amidst AI-Driven Growth

March 25, 2026
Gossamer Bio Stock

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Zscaler’s Upward Revision: Security Demand in the AI Era Fuels Optimism
  • Coherent Stock Accelerates Toward New Highs on Key Breakthroughs
  • Corning’s Strategic Alliance with Meta Fuels Investor Confidence

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com